Search

Daniel Adrian Hutta

from Pennington, NJ
Age ~53
Get Report
Also known as:
Daniel A Hutta
Connected to:
Kris Hutta, 52Charles Huttanus, 92Megan A Hutte, 30Erin N Huttel, 35Jacob A Huttel, 35Ann H Hutteman, 84Kate N Huttemann, 62Carl W Huttenberger, 86Dawn M Huttenbrauck, 51Eric H Hutten, 56

Daniel Hutta Phones & Addresses

  • Pennington, NJ
  • 78 Clearview Ave, Princeton, NJ 08540 (609) 497-3428
  • 1203 Rhoads Dr, Belle Mead, NJ 08502
  • 628 Lancaster Ct, Belle Mead, NJ 08502
  • 3544 Green Brier Blvd, Ann Arbor, MI 48105
  • Lewisburg, PA
  • 78 Clearview Ave, Princeton, NJ 08540

Work

Company: Articulatescience Jan 2018 to Sep 2018 Position: Vp, medical and scientific services

Education

Degree: Doctorates, Doctor of Philosophy School / High School: University of Michigan 1994 to 2000 Specialities: Chemistry

Skills

Oncology • Pharmaceutical Industry • Drug Discovery • Medical Writing • Clinical Development • Medicinal Chemistry • Biotechnology • Chemistry • Organic Chemistry • Life Sciences • Drug Design • Lifesciences • Clinical Trials • Drug Development • Pharmacology • Scientific Writing • Organic Synthesis • Publication Planning • Advisory Boards • Scientific Communications • Manuscript Development • Gap Analysis • Competitive Intelligence • Oncology Clinical Research • Clinical Trial Analysis • Symposia • Lexicon

Industries

Pharmaceuticals

Resumes

Resumes

Daniel Hutta Photo 1

Svp, Scientific Strategy

View page
Location:
Princeton, NJ
Industry:
Pharmaceuticals
Work:
Articulatescience Jan 2018 - Sep 2018
Vp, Medical and Scientific Services
Proed Communications Health Consultancy Group Jan 2018 - Sep 2018
Svp, Scientific Strategy
Chrysalis Medical Communications May 2016 - Dec 2017
Vp, Medical and Scientific Services
Articulatescience Dec 2007 - May 2016
Director, Scientific and Editorial Services
Johnson & Johnson Apr 2001 - Nov 2007
Research Scientist
Education:
University of Michigan 1994 - 2000
Doctorates, Doctor of Philosophy, Chemistry Bucknell University 1990 - 1994
Bachelors, Bachelor of Science, Chemistry William Tennent High School 1988 - 1990
Skills:
Oncology
Pharmaceutical Industry
Drug Discovery
Medical Writing
Clinical Development
Medicinal Chemistry
Biotechnology
Chemistry
Organic Chemistry
Life Sciences
Drug Design
Lifesciences
Clinical Trials
Drug Development
Pharmacology
Scientific Writing
Organic Synthesis
Publication Planning
Advisory Boards
Scientific Communications
Manuscript Development
Gap Analysis
Competitive Intelligence
Oncology Clinical Research
Clinical Trial Analysis
Symposia
Lexicon

Publications

Us Patents

5-Oxo-5,8-Dihydro-Pyrido-Pyrimidine As Inhibitors Of C-Fms Kinase

View page
US Patent:
7642270, Jan 5, 2010
Filed:
Sep 12, 2006
Appl. No.:
11/519611
Inventors:
Mark R. Player - Phoenixville PA, US
Hui Huang - Monroe Township NJ, US
Daniel A. Hutta - Belle Mead NJ, US
Renee L. DesJarlais - Saint Davids PA, US
Assignee:
Janssen Pharmaceutica N.V. - Beerse
International Classification:
A61K 31/44
C07D 471/06
US Classification:
514303, 544279
Abstract:
The invention addresses the current need for selective and potent protein tyrosine kinase inhibitors by providing potent inhibitors of c-fms kinase. The invention is directed to the novel compounds of Formula I:.

Hetero Isonipecotic Modulators Of Vanilloid Vr1 Receptor

View page
US Patent:
8604190, Dec 10, 2013
Filed:
Oct 6, 2009
Appl. No.:
12/574444
Inventors:
Micheal D. Gaul - Spring House PA, US
Daniel A. Hutta - Belle Mead NJ, US
Assignee:
Janssen Pharmaceutica NV - Beerse
International Classification:
C07D 413/02
US Classification:
544129, 5142352
Abstract:
This invention is directed to vanilloid receptor VR1 ligands. More particularly, this invention relates to hetero isonipecotic amides that are potent modulators of VR1 which are useful for the treatment and prevention of disease conditions in mammals.

Hetero Isonipecotic Modulators Of Vanilloid Vr1 Receptor

View page
US Patent:
20050288281, Dec 29, 2005
Filed:
Jun 27, 2005
Appl. No.:
11/168213
Inventors:
Michael Gaul - Yardley PA, US
Daniel Hutta - Belle Mead NJ, US
International Classification:
A61K031/541
A61K031/5377
A61K031/4545
A61K031/454
C07D417/02
C07D413/02
US Classification:
514227500, 514235200, 514316000, 514326000, 544060000, 544124000, 546190000, 546209000
Abstract:
This invention is directed to vanilloid receptor VR1 ligands. More particularly, this invention relates to hetero isonipecotic amides that are potent modulators of VR1 which are useful for the treatment and prevention of disease conditions in mammals.

5-Oxo-5,8-Dihydro-Pyrido-Pyrimidines As Inhibitors Of C-Fms Kinase

View page
US Patent:
20080114007, May 15, 2008
Filed:
Oct 19, 2007
Appl. No.:
11/875294
Inventors:
Mark Player - Phoenixville PA, US
William Parsons - Belle Mead NJ, US
Hui Huang - Monroe Twp. NJ, US
Daniel Hutta - Belle Mead NJ, US
Huaping Hu - Pennington NJ, US
James Rinker - Reading PA, US
International Classification:
A61K 31/519
C07D 471/04
C07D 401/02
C07D 401/14
A61P 35/00
A61P 9/00
US Classification:
514264110, 544279000
Abstract:
The invention addresses the current need for selective and potent protein tyrosine kinase inhibitors by providing potent inhibitors of c-fms kinase. The invention is directed to the novel compounds of Formula I: or a salt, stereoisomer, tautomer, crystalline, polymorph, amorphous, solvate, hydrate, ester, prodrug or metabolite form thereof, wherein A, Y, Z, Rand Rare described in the specification.
Control profile
Daniel Adrian Hutta from Pennington, NJ, age ~53 Get Report